HTFL · XBRL financial data

Heartflow financial statements, every quarter

The same tables from 5 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (HTFL's year ends in late December)

In millions of dollars	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	43	46	49*	53	64
Cost of revenue	11	11	10*	10	11
Gross profit	33	35	39*	42	53
Research and development	15	17	19*	22	26
Selling, general and administrative	31	33	38*	43	45
General and administrative	8	—	year only	13	14
Total operating expenses	46	51	57*	72	71
Operating income (loss)	(14)	(15)	(18)*	(30)	(18)
Interest income	1	2	3*	2	2
Interest expense	7	3	0*	0	0*
Other income (expense)	(0)	(0)	(0)*	(0)	(0)
Income tax expense (benefit)	0	0	(0)*	0	0
Net income (loss)	(9)	(51)	(24)*	(27)	(16)
Earnings per share, basic USD per share	(1.46)	(1.04)	—	(0.32)	(0.18)
Earnings per share, diluted USD per share	(1.46)	(1.04)	—	(0.32)	(0.18)
Weighted average shares, basic millions of shares	6	49	—	86	86
Weighted average shares, diluted millions of shares	6	49	—	86	86

Fiscal quarters (HTFL's year ends in late December)

In millions of dollars	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	80	291	45	20	34
Short-term investments	—	—	132	139	128
Accounts receivable	30	28	29	36	43
Prepaid and other current assets	9	9	14	18	19
Total current assets	118	328	220	212	224
Property and equipment, net	8	8	9	10	10
Right-of-use asset	18	17	17	14	15
Total assets	159	364	359	344	344
Accounts payable	2	2	3	6	5
Total current liabilities	33	38	42	38	44
Lease liability, non-current	17	16	16	20	20
Total liabilities	286	110	59	58	65
Accumulated deficit	(1,013)	(1,063)	(1,088)	(1,115)	(1,131)
Total stockholders' equity	(895)	255	301	286	280
Total liabilities and equity	159	364	359	344	344
Common shares outstanding (cover page) millions of shares	83	85	86	86	87

Fiscal quarters (HTFL's year ends in late December)

In millions of dollars	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(9)	(51)	(24)*	(27)	(16)
Stock-based compensation	2*	4*	5*	7	8*
Depreciation and amortization	1*	1*	1*	1	1*
Net cash from operating activities	(27)*	(3)*	(11)*	(30)	(9)*
Purchases of property and equipment	1*	1*	2*	2	2*
Net cash from investing activities	(1)*	(1)*	(235)*	(1)	21*
Proceeds from issuing common stock	—	—	—	3	0*
Repayments of long-term debt	—	—	0*	—	—
Net cash from financing activities	(2)*	215*	(0)*	6	2*
Net change in cash	(30)*	211*	(246)*	(25)	15*

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Heartflow	34	64	(8.6)*	87.0M	19.0 quarters	Q2 FY26 10-QJun 30, 2026
Mimedx Group	121	62	3.9*	145.9M	—	Q3 FY26 10-QSep 30, 2026
Establishment Labs Holdings	71	68	(17)*	29.8M	4.3 quarters	Q2 FY26 10-QJun 30, 2026
Lemaitre Vascular	27	not reported	16*	22.9M	—	Q2 FY26 10-QJun 30, 2026
Cerus	16	58	3*	202.0M	—	Q3 FY26 10-QSep 30, 2026
SkinHealth Systems	206	72	2.7*	130.1M	—	Q2 FY26 10-QJun 30, 2026
Orthopediatrics	17	73	4.5*	26.1M	—	Q3 FY26 10-QSep 30, 2026
SI-BONE	35	56	5.9*	45.1M	—	Q3 FY26 10-QSep 30, 2026
Axogen	329	76	17*	59.7M	—	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.